A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis

NCT00870467 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Double-blind adalimumab
DRUG: Double-blind Placebo
BIOLOGICAL: Open-label Adalimumab
BIOLOGICAL: Open-labelAdalimumabRescue

Sponsor

Abbott

Collaborators

[object Object]